Rampant Off-label Use Leads to NovoSeven Blood Clot Risks: Studies
Researchers say the widespread off-label use of the hemophilia drug NovoSeven by U.S. hospitals may be putting patients at an unnecessary risk of blood clots, as there are no signs…
Researchers say the widespread off-label use of the hemophilia drug NovoSeven by U.S. hospitals may be putting patients at an unnecessary risk of blood clots, as there are no signs…